US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MBX Biosciences

30.54

-2.4300-7.37%

Post-market: 30.540.00000.00%17:30 EST

Volume:508.03K

Turnover:15.87M

Market Cap:1.37B

PE:-12.77

High:32.19

Open:31.90

Low:30.33

Close:32.97

52wk High:44.89

52wk Low:4.81

Shares:44.90M

Float Shares:25.72M

Volume Ratio:0.82

T/O Rate:1.98%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3917

EPS(LYR):-5.8181

ROE:-24.43%

ROA:-16.64%

PB:3.54

PE(LYR):-5.25

Loading ...

Overview Company News Filings

BRIEF-Mbx Biosciences To Offer Up To $400 Million In Securities - SEC Filing

Mbx Biosciences Inc - to Offer up to $400 Mln in Securities - SEC Filing

THOMSON REUTERS

MBX Biosciences Q3 EPS $(0.63) Beats $(0.70) Estimate

MBX Biosciences reports positive Phase 2 results for canvuparatide and posts Q3 financials

Mbx Biosciences Inc - Qtrly Net Loss per Common Share, Basic and Diluted $0.63

THOMSON REUTERS

Mbx Biosciences Inc - $391.7 Mln in Cash, Cash Equivalents & Marketable Securities as of Sept 30; Expected to Support Operations Into 2029

THOMSON REUTERS

TD Cowen Initiates MBX Biosciences at Buy

MT Newswires Live

Mbx Biosciences Inc : TD Cowen Initiates Coverage With Buy Rating

THOMSON REUTERS

Buy Rating for MBX Biosciences Driven by Promising PEP Platform and Successful Phase II Trials

MBX Biosciences initiated with a Buy at TD Cowen

Biotech Stocks Are Coming Back. Here's What's Driving The Sector Higher.

MBX Biosciences, Inc. (MBX) Gets a Buy from Truist Financial

Biotech is back. Here's why these rallying stocks belong in your portfolio now.

MBX Biosciences Advances Phase 2a Study on PBH Treatment with Imapextide

MBX Biosciences’ New Study on Obesity Treatment: A Potential Game-Changer?

Top Executive Makes Major Move with MBX Biosciences Stock!

Director’s Bold Move: Major Investment in MBX Biosciences!

MBX Biosciences Director Steven L. Hoerter Reports Acquisition of Common Shares

MBX Biosciences to Present at Guggenheim Healthcare Innovation Conference

MBX Biosciences to Participate in November Investor Conferences

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MBX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MBX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MBX\",,,,,undefined,":{"symbol":"MBX","market":"US","secType":"STK","nameCN":"MBX Biosciences","latestPrice":30.54,"timestamp":1772571600000,"preClose":32.97,"halted":0,"volume":508033,"hourTrading":{"tag":"盘后","latestPrice":30.54,"preClose":30.54,"latestTime":"17:30 EST","volume":13288,"amount":405814.67,"timestamp":1772577050398,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.07370336669699726,"floatShares":25718200,"shares":44902302,"eps":-2.391686,"marketStatus":"Not Yet Opened","change":-2.43,"latestTime":"03-03 16:00:00 EST","open":31.9,"high":32.19,"low":30.33,"amount":15872759.517479999,"amplitude":0.056415,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.391686,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772614800000},"marketStatusCode":0,"adr":0,"listingDate":1726200000000,"exchange":"NASDAQ","adjPreClose":32.97,"preHourTrading":{"tag":"盘前","latestPrice":31.74,"preClose":32.97,"latestTime":"09:20 EST","volume":3406,"amount":109667.81852,"timestamp":1772547634855,"change":-1.23,"changeRate":-0.037307,"amplitude":0.090689},"postHourTrading":{"tag":"盘后","latestPrice":30.54,"preClose":30.54,"latestTime":"17:30 EST","volume":13288,"amount":405814.67,"timestamp":1772577050398,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.817272,"impliedVol":0.647,"impliedVolPercentile":0.0311},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MBX\",,,,,undefined,":{"symbol":"MBX","floatShares":25718200,"roa":"-16.64%","roe":"-24.43%","lyrEps":-5.818121,"volumeRatio":0.817272,"shares":44902302,"dividePrice":0,"high":32.19,"amplitude":0.056415,"preClose":32.97,"low":30.33,"week52Low":4.8069,"pbRate":"3.54","week52High":44.89,"institutionHeld":0,"latestPrice":30.54,"eps":-2.391686,"divideRate":0,"volume":508033,"delay":0,"ttmEps":-2.391686,"open":31.9,"prevYearClose":31.54,"prevWeekClose":32.55,"prevMonthClose":32.55,"prevQuarterClose":31.54,"fiveDayClose":36.73,"twentyDayClose":39.07,"sixtyDayClose":33.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MBX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"MBX","fiscalQuarterEnding":"2025/09","expectedEps":-0.73,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.63},{"market":"US","date":"2025-08-07","symbol":"MBX","fiscalQuarterEnding":"2025/06","expectedEps":-0.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.58},{"market":"US","date":"2025-05-12","symbol":"MBX","fiscalQuarterEnding":"2025/03","expectedEps":-0.81,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-0.71},{"market":"US","date":"2025-03-17","symbol":"MBX","fiscalQuarterEnding":"2024/12","expectedEps":-0.59,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"pre","actualEps":-0.47}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MBX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MBX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3636,"buy":0.5455,"hold":0,"sell":0.0909,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1769576400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MBX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MBX","date":"2026-03-02","current":-12.769235,"percent":0.095368,"low":-24.064666,"twenty":-16.374987,"median":-8.689968,"eighty":-5.437516,"high":-3.125337,"avg":-10.533562,"sd":5.677443,"marketCap":1534839524},"quantilePoints":[{"date":"2024-09-13","current":-15.960592,"twenty":-13.895501,"median":-10.797864,"eighty":-10.797864,"marketCap":753339957},{"date":"2024-09-20","current":-15.949203,"twenty":-15.694582,"median":-15.111074,"eighty":-12.419885,"marketCap":752802389},{"date":"2024-09-27","current":-16.939398,"twenty":-16.33255,"median":-15.751164,"eighty":-14.917986,"marketCap":799539567},{"date":"2024-10-04","current":-16.797941,"twenty":-16.986079,"median":-16.110499,"eighty":-15.091977,"marketCap":792862827},{"date":"2024-10-11","current":-16.932325,"twenty":-16.986079,"median":-16.31699,"eighty":-15.248994,"marketCap":799205730},{"date":"2024-10-18","current":-17.024271,"twenty":-17.032759,"median":-16.518565,"eighty":-15.369232,"marketCap":803545610},{"date":"2024-10-25","current":-15.022664,"twenty":-17.021442,"median":-16.380645,"eighty":-15.369232,"marketCap":709069745},{"date":"2024-11-01","current":-15.885548,"twenty":-16.991737,"median":-16.362963,"eighty":-15.369232,"marketCap":749797857},{"date":"2024-11-08","current":-13.874718,"twenty":-16.947885,"median":-16.309917,"eighty":-15.248994,"marketCap":765593046},{"date":"2024-11-15","current":-10.66494,"twenty":-16.936569,"median":-16.143706,"eighty":-14.480386,"marketCap":588480730},{"date":"2024-11-22","current":-11.203941,"twenty":-16.918179,"median":-15.949203,"eighty":-13.805677,"marketCap":618222233},{"date":"2024-11-29","current":-12.318278,"twenty":-16.877157,"median":-15.751164,"eighty":-12.380051,"marketCap":679710282},{"date":"2024-12-06","current":-13.432616,"twenty":-16.771064,"median":-15.461179,"eighty":-11.837418,"marketCap":741198331},{"date":"2024-12-13","current":-11.470413,"twenty":-16.663558,"median":-15.31265,"eighty":-11.837418,"marketCap":632925896},{"date":"2024-12-20","current":-12.330391,"twenty":-16.662143,"median":-15.019127,"eighty":-11.803503,"marketCap":680378630},{"date":"2024-12-27","current":-12.154761,"twenty":-16.656485,"median":-14.542475,"eighty":-11.803503,"marketCap":670687579},{"date":"2025-01-03","current":-11.258446,"twenty":-16.435813,"median":-14.054537,"eighty":-11.676323,"marketCap":621229800},{"date":"2025-01-10","current":-8.290916,"twenty":-16.380645,"median":-13.850493,"eighty":-11.492215,"marketCap":457484452},{"date":"2025-01-17","current":-5.989566,"twenty":-16.372157,"median":-13.75965,"eighty":-11.117943,"marketCap":330498264},{"date":"2025-01-24","current":-6.510398,"twenty":-16.36367,"median":-13.256987,"eighty":-10.797864,"marketCap":359237243},{"date":"2025-01-31","current":-6.06224,"twenty":-16.342452,"median":-12.878476,"eighty":-9.893382,"marketCap":334508354},{"date":"2025-02-07","current":-7.473331,"twenty":-16.314161,"median":-12.457571,"eighty":-8.809325,"marketCap":412370938},{"date":"2025-02-14","current":-6.304488,"twenty":-16.290113,"median":-12.324334,"eighty":-7.444262,"marketCap":347875321},{"date":"2025-02-21","current":-6.589128,"twenty":-16.247676,"median":-12.215323,"eighty":-7.171733,"marketCap":363581507},{"date":"2025-02-28","current":-5.813937,"twenty":-16.175534,"median":-12.009413,"eighty":-6.798672,"marketCap":320807212},{"date":"2025-03-07","current":-5.989566,"twenty":-16.064646,"median":-11.803503,"eighty":-6.591551,"marketCap":330498264},{"date":"2025-03-14","current":-5.26888,"twenty":-15.958314,"median":-11.682379,"eighty":-6.514032,"marketCap":290731536},{"date":"2025-03-21","current":-4.258879,"twenty":-15.936472,"median":-11.549143,"eighty":-6.294798,"marketCap":263718287},{"date":"2025-03-28","current":-4.188707,"twenty":-15.858671,"median":-11.258446,"eighty":-6.213645,"marketCap":259373118},{"date":"2025-04-04","current":-3.260282,"twenty":-15.749749,"median":-11.107042,"eighty":-6.057395,"marketCap":201883200},{"date":"2025-04-11","current":-3.999783,"twenty":-15.687509,"median":-10.797864,"eighty":-5.922948,"marketCap":247674589},{"date":"2025-04-17","current":-4.113138,"twenty":-15.461179,"median":-10.66494,"eighty":-5.686757,"marketCap":254693707},{"date":"2025-04-25","current":-4.949799,"twenty":-15.461179,"median":-9.901861,"eighty":-5.438453,"marketCap":306501482},{"date":"2025-05-02","current":-6.477382,"twenty":-15.454106,"median":-9.653557,"eighty":-5.327647,"marketCap":401092452},{"date":"2025-05-09","current":-5.996976,"twenty":-15.31265,"median":-8.539219,"eighty":-5.438453,"marketCap":371344761},{"date":"2025-05-16","current":-5.077465,"twenty":-15.206557,"median":-7.473331,"eighty":-5.077465,"marketCap":373015980},{"date":"2025-05-23","current":-5.691675,"twenty":-15.022664,"median":-7.246225,"eighty":-5.226487,"marketCap":418138881},{"date":"2025-05-30","current":-5.787218,"twenty":-15.017006,"median":-7.134185,"eighty":-5.260401,"marketCap":425157999},{"date":"2025-06-06","current":-5.395944,"twenty":-14.885451,"median":-6.813207,"eighty":-5.315894,"marketCap":396413040},{"date":"2025-06-13","current":-4.877278,"twenty":-14.35621,"median":-6.707223,"eighty":-5.172099,"marketCap":358309257},{"date":"2025-06-20","current":-4.677092,"twenty":-14.130289,"median":-6.595185,"eighty":-5.059804,"marketCap":343602533},{"date":"2025-06-27","current":-5.136611,"twenty":-14.052953,"median":-6.564904,"eighty":-5.017962,"marketCap":377361148},{"date":"2025-07-03","current":-5.673476,"twenty":-13.977856,"median":-6.515167,"eighty":-5.013234,"marketCap":416801906},{"date":"2025-07-11","current":-5.641628,"twenty":-13.855338,"median":-6.4303,"eighty":-5.035235,"marketCap":414462200},{"date":"2025-07-18","current":-5.548359,"twenty":-13.804466,"median":-6.320845,"eighty":-5.055522,"marketCap":407610204},{"date":"2025-07-25","current":-5.928259,"twenty":-13.766918,"median":-6.298431,"eighty":-5.072006,"marketCap":435519554},{"date":"2025-08-01","current":-6.028352,"twenty":-13.628836,"median":-6.310434,"eighty":-5.101123,"marketCap":442872915},{"date":"2025-08-08","current":-4.830149,"twenty":-13.362364,"median":-6.283291,"eighty":-5.101123,"marketCap":372013249},{"date":"2025-08-15","current":-5.76189,"twenty":-13.198847,"median":-6.22399,"eighty":-5.101123,"marketCap":443774969},{"date":"2025-08-22","current":-6.171895,"twenty":-13.089836,"median":-6.221845,"eighty":-5.14935,"marketCap":475353203},{"date":"2025-08-29","current":-6.224236,"twenty":-12.914207,"median":-6.224236,"eighty":-5.170279,"marketCap":479384467},{"date":"2025-09-05","current":-5.635398,"twenty":-12.685283,"median":-6.241684,"eighty":-5.176649,"marketCap":434032748},{"date":"2025-09-12","current":-4.331231,"twenty":-12.593229,"median":-6.221845,"eighty":-5.070186,"marketCap":333587089},{"date":"2025-09-19","current":-4.392296,"twenty":-12.449092,"median":-6.213645,"eighty":-5.008506,"marketCap":338290230},{"date":"2025-09-26","current":-10.057984,"twenty":-12.39822,"median":-6.217295,"eighty":-5.008506,"marketCap":774655869},{"date":"2025-10-03","current":-9.721364,"twenty":-12.327968,"median":-6.224236,"eighty":-5.029502,"marketCap":748729706},{"date":"2025-10-10","current":-9.207959,"twenty":-12.309799,"median":-6.253122,"eighty":-5.039662,"marketCap":709187798},{"date":"2025-10-17","current":-7.994552,"twenty":-12.25166,"median":-6.280939,"eighty":-5.051241,"marketCap":615732407},{"date":"2025-10-24","current":-9.364715,"twenty":-12.13417,"median":-6.307461,"eighty":-5.070186,"marketCap":721260982},{"date":"2025-10-31","current":-12.650784,"twenty":-12.13417,"median":-6.352937,"eighty":-5.089294,"marketCap":974350701},{"date":"2025-11-07","current":-13.743232,"twenty":-12.309799,"median":-6.369154,"eighty":-5.142981,"marketCap":1106261420},{"date":"2025-11-14","current":-13.426901,"twenty":-12.512852,"median":-6.477382,"eighty":-5.169369,"marketCap":1080798409},{"date":"2025-11-21","current":-15.07807,"twenty":-12.739549,"median":-6.521866,"eighty":-5.176649,"marketCap":1213709223},{"date":"2025-11-28","current":-19.239461,"twenty":-13.256987,"median":-6.567932,"eighty":-5.191208,"marketCap":1548680395},{"date":"2025-12-05","current":-17.036043,"twenty":-13.72255,"median":-6.589128,"eighty":-5.211681,"marketCap":1371316303},{"date":"2025-12-12","current":-15.859028,"twenty":-13.826268,"median":-6.619611,"eighty":-5.226487,"marketCap":1276572445},{"date":"2025-12-19","current":-15.992906,"twenty":-14.046615,"median":-6.70403,"eighty":-5.26888,"marketCap":1287348998},{"date":"2025-12-26","current":-17.911832,"twenty":-14.268105,"median":-6.806351,"eighty":-5.279538,"marketCap":1441812917},{"date":"2026-01-02","current":-17.59387,"twenty":-14.917986,"median":-6.813207,"eighty":-5.295223,"marketCap":1416218605},{"date":"2026-01-09","current":-17.136452,"twenty":-15.146199,"median":-7.076651,"eighty":-5.307262,"marketCap":1379398717},{"date":"2026-01-16","current":-22.820712,"twenty":-15.452731,"median":-7.200803,"eighty":-5.317689,"marketCap":1836953174},{"date":"2026-01-23","current":-23.646296,"twenty":-15.472295,"median":-7.424882,"eighty":-5.324948,"marketCap":1903408581},{"date":"2026-01-30","current":-20.550355,"twenty":-15.847871,"median":-7.61062,"eighty":-5.334947,"marketCap":1654200805},{"date":"2026-02-06","current":-20.109671,"twenty":-15.97998,"median":-7.994552,"eighty":-5.365916,"marketCap":1618727987},{"date":"2026-02-13","current":-22.260078,"twenty":-16.085028,"median":-8.265761,"eighty":-5.405044,"marketCap":1791824944},{"date":"2026-02-20","current":-21.826592,"twenty":-16.300015,"median":-8.354645,"eighty":-5.422333,"marketCap":1756931510},{"date":"2026-02-27","current":-20.526135,"twenty":-16.365085,"median":-8.65641,"eighty":-5.437203,"marketCap":1652251211},{"date":"2026-03-02","current":-19.067514,"twenty":-16.374987,"median":-8.689968,"eighty":-5.437516,"marketCap":1534839524}],"updateTime":1772604232829},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MBX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2581524096","title":"BRIEF-Mbx Biosciences To Offer Up To $400 Million In Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581524096","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581524096?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:39","pubTimestamp":1762436368,"startTime":"0","endTime":"0","summary":"BRIEF-Mbx Biosciences To Offer Up To $400 Million In Securities - SEC FilingNov 6  - MBX Biosciences Inc MBX.O:MBX BIOSCIENCES INC - TO OFFER UP TO $400 MILLION IN SECURITIES - SEC FILINGSource text: [ID:n0001193125-25-268202]Further company coverage: MBX.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI298:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MBX"],"gpt_icon":0},{"id":"2581096138","title":"Mbx Biosciences Inc - to Offer up to $400 Mln in Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581096138","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581096138?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:38","pubTimestamp":1762436291,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI298:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MBX"],"gpt_icon":0},{"id":"2581953960","title":"MBX Biosciences Q3 EPS $(0.63) Beats $(0.70) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2581953960","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581953960?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:14","pubTimestamp":1762434865,"startTime":"0","endTime":"0","summary":"MBX Biosciences (NASDAQ:MBX) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.70) by 9.87 percent. This is a 77.34 percent increase over losses of $(2.78) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48684366/mbx-biosciences-q3-eps-0-63-beats-0-70-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBX"],"gpt_icon":0},{"id":"2581936880","title":"MBX Biosciences reports positive Phase 2 results for canvuparatide and posts Q3 financials","url":"https://stock-news.laohu8.com/highlight/detail?id=2581936880","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581936880?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:01","pubTimestamp":1762434106,"startTime":"0","endTime":"0","summary":"MBX Biosciences Inc. reported cash, cash equivalents, and marketable securities of $391.7 million as of September 30, 2025, including proceeds from its recent public offering, which raised approximately $200 million in gross proceeds. Research and development expenses for the third quarter of 2025 were $19.3 million, up from $16.7 million in the same period of 2024. The increase was attributed to costs associated with ongoing clinical trials. The company announced positive topline results from the Phase 2 Avail trial of canvuparatide in hypoparathyroidism and completed an upsized public offering. MBX expects its cash position to support operations into 2029 and has outlined milestones for 2026, including Phase 3 trial initiation for canvuparatide and clinical data readouts for other pipeline programs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL7p7dnS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00B3QW5Z07.USD","MBX","LU2095319765.USD","LU2210149790.SGD","BK4112","NDAQ","IE00B64PRP62.GBP","LU2210150020.SGD","BK4585","BK4588","LU0314104364.USD","IE00BGHQF748.EUR","BK4007"],"gpt_icon":0},{"id":"2581709591","title":"Mbx Biosciences Inc - Qtrly Net Loss per Common Share, Basic and Diluted $0.63","url":"https://stock-news.laohu8.com/highlight/detail?id=2581709591","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581709591?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:00","pubTimestamp":1762434009,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nTUA33LXD7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBX","BK4007"],"gpt_icon":0},{"id":"2581309555","title":"Mbx Biosciences Inc - $391.7 Mln in Cash, Cash Equivalents & Marketable Securities as of Sept 30; Expected to Support Operations Into 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2581309555","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581309555?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:00","pubTimestamp":1762434009,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nTUA33LXD7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MBX"],"gpt_icon":0},{"id":"2580368937","title":"TD Cowen Initiates MBX Biosciences at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2580368937","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580368937?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:14","pubTimestamp":1762258496,"startTime":"0","endTime":"0","summary":"MBX Biosciences (MBX) has an average rating of buy and mean price target of $59, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4207","BK4566","COWN","BK4585","BK4007","TD","MBX","BK4127"],"gpt_icon":0},{"id":"2580389637","title":"Mbx Biosciences Inc : TD Cowen Initiates Coverage With Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2580389637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580389637?lang=en_us&edition=fundamental","pubTime":"2025-11-04 19:41","pubTimestamp":1762256497,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nFWN3WG0OU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MBX"],"gpt_icon":0},{"id":"2580489782","title":"Buy Rating for MBX Biosciences Driven by Promising PEP Platform and Successful Phase II Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2580489782","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580489782?lang=en_us&edition=fundamental","pubTime":"2025-11-04 18:45","pubTimestamp":1762253126,"startTime":"0","endTime":"0","summary":"MBX Biosciences, Inc. (MBX) has received a new Buy rating, initiated by TD Cowen analyst, Tyler Van Buren. Tyler Van Buren has given his Buy rating...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-mbx-biosciences-driven-by-promising-pep-platform-and-successful-phase-ii-trials-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-mbx-biosciences-driven-by-promising-pep-platform-and-successful-phase-ii-trials-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PEP","MBX"],"gpt_icon":0},{"id":"2580782541","title":"MBX Biosciences initiated with a Buy at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2580782541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580782541?lang=en_us&edition=fundamental","pubTime":"2025-11-04 18:40","pubTimestamp":1762252822,"startTime":"0","endTime":"0","summary":"TD Cowen initiated coverage of MBX Biosciences (MBX) with a Buy rating and no price target The firm believes the company’s Prostate Secretory Prote...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mbx-biosciences-initiated-with-a-buy-at-td-cowen-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mbx-biosciences-initiated-with-a-buy-at-td-cowen-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","TD","COWN","MBX","BK4207","BK4566","BK4007","BK4127"],"gpt_icon":0},{"id":"2580759232","title":"Biotech Stocks Are Coming Back. Here's What's Driving The Sector Higher.","url":"https://stock-news.laohu8.com/highlight/detail?id=2580759232","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580759232?lang=en_us&edition=fundamental","pubTime":"2025-11-04 10:55","pubTimestamp":1762224956,"startTime":"0","endTime":"0","summary":"Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a8e8b2c49707183fd768f0d17d08b819","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","ABBV","LU2264538146.SGD","LU0965509283.SGD","AMGN","LU1267930573.SGD","LU0985481810.HKD","SG9999015952.SGD","BMY","IE0002141913.USD","ARGX","ALKS","LU0471298777.SGD","BBIO","ALNY","LU1074936037.SGD","LU0170899867.USD","PFE","QURE","LU0795875169.SGD","LU2087625088.SGD","RAPP","LU1868836591.USD","LU0006306889.USD","SG9999003800.SGD","LU1868837136.USD","IE00BFXG1179.USD","IE00BLSP4239.USD","LU1868836757.USD","NBIX","PRAX","SG9999013999.USD","IE00BWXC8680.SGD","MBX","LU1291159041.SGD","SG9999001176.USD","MDGL","IE00BN8TJ469.HKD","IE00BBT3K403.USD","LU0211327993.USD","SG9999014906.USD","LU1868836914.USD","LLY","LU0672654240.SGD","LU1868837300.USD","LU2347655156.SGD","ASND","LU1814569148.SGD","LU1548497426.USD","LU0154245673.USD"],"gpt_icon":1},{"id":"2580241339","title":"MBX Biosciences, Inc. (MBX) Gets a Buy from Truist Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2580241339","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580241339?lang=en_us&edition=fundamental","pubTime":"2025-11-04 02:25","pubTimestamp":1762194338,"startTime":"0","endTime":"0","summary":"In a report released today, Srikripa Devarakonda from Truist Financial reiterated a Buy rating on MBX Biosciences, Inc.. The company’s shares opene...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mbx-biosciences-inc-mbx-gets-a-buy-from-truist-financial-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mbx-biosciences-inc-mbx-gets-a-buy-from-truist-financial-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MBX"],"gpt_icon":0},{"id":"2580214052","title":"Biotech is back. Here's why these rallying stocks belong in your portfolio now.","url":"https://stock-news.laohu8.com/highlight/detail?id=2580214052","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580214052?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:58","pubTimestamp":1762181880,"startTime":"0","endTime":"0","summary":"The volatile sector is seeing greater stability, and these four stocks can profit. Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9 percentage points.Biotech's strength is likely to continue - so it's not too late for investors to get in, sector analysts say.\"Biotech will be a comparative outperformer,\" says Motley Fool biotech analyst Karl Thiel. \"There is better sentiment and fund-flow, and that feeds on itself. That can unravel quickly but I still think it has some legs.\". Stifel's head of biotech research, Paul Matteis, agrees. \"The sector's run has been driven by a number of credible fundamental factors that seem mostly sustainable,\" he said in a recent interview.M&A also puts higher valuations on biotech companies in general because investors start considering how much more profitable potential drugs might be in the hands of companies ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QURE","BBIO","AMGN","MBX","BMY","LU0965508806.USD","LU2237443978.SGD","LU0545039389.USD","LU1162221912.USD","LU0238689110.USD","LU1670711123.USD","GB00BDT5M118.USD","ALKS","LU2129689605.HKD","RAPP","LU1093756325.SGD","LU1093756168.USD","ABBV","ARGX","LU1670710661.SGD","BK4533","LU2237443549.SGD","LU2491050071.SGD","IE00B1XK9C88.USD","LU1366192091.USD","LU0097036916.USD","LU2237443382.USD","PRAX","NBIX","LU2491049909.HKD","LU1670710588.SGD","BK4534","LU0471298694.HKD","LU1267930730.SGD","LU2491050154.USD","MDGL","LU0109391861.USD","LU2357305700.SGD","LU0985320562.USD","ASND","LU0124676726.USD","LU0310799852.SGD","LU2065170008.USD","ALNY","LU2237443622.USD","LU2461242641.AUD","LU0661504455.SGD","LU1066053197.SGD"],"gpt_icon":1},{"id":"2578067046","title":"MBX Biosciences Advances Phase 2a Study on PBH Treatment with Imapextide","url":"https://stock-news.laohu8.com/highlight/detail?id=2578067046","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578067046?lang=en_us&edition=fundamental","pubTime":"2025-10-28 07:34","pubTimestamp":1761608070,"startTime":"0","endTime":"0","summary":"MBX Biosciences, Inc. (($MBX)) announced an update on their ongoing clinical study. MBX Biosciences, Inc. (MBX) is conducting an exploratory Phase ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mbx-biosciences-advances-phase-2a-study-on-pbh-treatment-with-imapextide?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mbx-biosciences-advances-phase-2a-study-on-pbh-treatment-with-imapextide?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PBH","MBX"],"gpt_icon":0},{"id":"2578750716","title":"MBX Biosciences’ New Study on Obesity Treatment: A Potential Game-Changer?","url":"https://stock-news.laohu8.com/highlight/detail?id=2578750716","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578750716?lang=en_us&edition=fundamental","pubTime":"2025-10-28 04:38","pubTimestamp":1761597502,"startTime":"0","endTime":"0","summary":"MBX Biosciences, Inc. (($MBX)) announced an update on their ongoing clinical study. MBX Biosciences, Inc. is conducting a study titled A Randomized...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mbx-biosciences-new-study-on-obesity-treatment-a-potential-game-changer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mbx-biosciences-new-study-on-obesity-treatment-a-potential-game-changer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MBX"],"gpt_icon":0},{"id":"2577038069","title":"Top Executive Makes Major Move with MBX Biosciences Stock!","url":"https://stock-news.laohu8.com/highlight/detail?id=2577038069","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577038069?lang=en_us&edition=fundamental","pubTime":"2025-10-22 10:01","pubTimestamp":1761098507,"startTime":"0","endTime":"0","summary":"New insider activity at MBX Biosciences, Inc. ( ($MBX) ) has taken place on October 21, 2025. President & CEO P. Kent Hawryluk has made a significa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-major-move-with-mbx-biosciences-stock-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-major-move-with-mbx-biosciences-stock-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MBX","BK4007"],"gpt_icon":0},{"id":"2577167288","title":"Director’s Bold Move: Major Investment in MBX Biosciences!","url":"https://stock-news.laohu8.com/highlight/detail?id=2577167288","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577167288?lang=en_us&edition=fundamental","pubTime":"2025-10-21 10:01","pubTimestamp":1761012095,"startTime":"0","endTime":"0","summary":"New insider activity at MBX Biosciences, Inc. ( ($MBX) ) has taken place on October 20, 2025. Director Steven Hoerter has made a significant invest...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/directors-bold-move-major-investment-in-mbx-biosciences-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/directors-bold-move-major-investment-in-mbx-biosciences-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MBX"],"gpt_icon":0},{"id":"2577894559","title":"MBX Biosciences Director Steven L. Hoerter Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2577894559","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577894559?lang=en_us&edition=fundamental","pubTime":"2025-10-21 06:50","pubTimestamp":1761000655,"startTime":"0","endTime":"0","summary":"Steven L. Hoerter, Director of MBX Biosciences Inc., reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MBX Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 20, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nNDL2n92qW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"MBX Biosciences Director Steven L. Hoerter Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBX","BK4007"],"gpt_icon":0},{"id":"2576859688","title":"MBX Biosciences to Present at Guggenheim Healthcare Innovation Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2576859688","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576859688?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:00","pubTimestamp":1760961638,"startTime":"0","endTime":"0","summary":"MBX Biosciences Inc., a clinical-stage biopharmaceutical company focused on novel precision peptide therapies for endocrine and metabolic disorders, will participate in the Guggenheim 2nd Annual Healthcare Innovation Conference on November 10, 2025. Company executives will present in a fireside chat and hold one-on-one meetings at the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MBX Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire  on October 20, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nNDLbh3Lfb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU2210149790.SGD","NDAQ","IE00BKPKM429.USD","LU0314104364.USD","IE00B3QW5Z07.USD","BK4112","LU2210150020.SGD","BK4585","IE00BGHQF748.EUR","MBX","BK4007","IE00B64PRP62.GBP","BK4588"],"gpt_icon":0},{"id":"2576548808","title":"MBX Biosciences to Participate in November Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2576548808","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576548808?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:00","pubTimestamp":1760961600,"startTime":"0","endTime":"0","summary":"CARMEL, Ind., Oct.  20, 2025  (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/20/3169301/0/en/MBX-Biosciences-to-Participate-in-November-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","PBH","BK4092","XBI","BK4588","HP","BK4581","LABU","BK4585","MBX","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":3,"totalSize":123,"code":"91000000","status":"200"}]}}